Trial Outcomes & Findings for Electroacupuncture for Major Depression (NCT NCT00071110)

NCT ID: NCT00071110

Last Updated: 2010-01-11

Results Overview

Number of participants whose Hamilton Depression Rating Scale score decreased at least 50% and had a final score less than 10. Minimum score = 0 (best). Maximum score = 52 (worst). The 17 item scale assesses depression symptoms, including Depressed Mood, Feelings of Guilt, Suicidal Ideation, Insomnia, Anxiety, Weight Change, and Insight.

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

57 participants

Primary outcome timeframe

Change from Baseline to Post-Intervention Endpoint

Results posted on

2010-01-11

Participant Flow

57 Participants were recruited from March 2004 - May 2007 at the UPMC Shadyside Center for Complementary Medicine.

Twenty-nine subjects were randomized to Sham and 28 to Electroacupuncture.

Participant milestones

Participant milestones
Measure
Electroacupuncture (EA)
Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.
Sham Acupuncture (SA)
Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.
Overall Study
STARTED
28
29
Overall Study
COMPLETED
28
25
Overall Study
NOT COMPLETED
0
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Electroacupuncture (EA)
Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.
Sham Acupuncture (SA)
Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.
Overall Study
Protocol Violation
0
4

Baseline Characteristics

Electroacupuncture for Major Depression

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Electroacupuncture (EA)
n=28 Participants
Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.
Sham Acupuncture (SA)
n=29 Participants
Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.
Total
n=57 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0.0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
28 Participants
n=5 Participants
25 Participants
n=7 Participants
53.0 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
4 Participants
n=7 Participants
4.0 Participants
n=5 Participants
Age Continuous
46.04 years
STANDARD_DEVIATION 11.32 • n=5 Participants
48.86 years
STANDARD_DEVIATION 13.12 • n=7 Participants
47.47 years
STANDARD_DEVIATION 12.35 • n=5 Participants
Sex: Female, Male
Female
21 Participants
n=5 Participants
18 Participants
n=7 Participants
39.0 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
11 Participants
n=7 Participants
18.0 Participants
n=5 Participants
Region of Enrollment
United States
28 participants
n=5 Participants
29 participants
n=7 Participants
57.0 participants
n=5 Participants

PRIMARY outcome

Timeframe: Change from Baseline to Post-Intervention Endpoint

Population: ITT, excluding the first four sham acupuncture subjects, whom the primary acupuncturist erred in treating. Although he correctly used the sham electricity procedure, for these subjects he placed needles in the verum electroacupuncture points of GV-20 and Yin tang.

Number of participants whose Hamilton Depression Rating Scale score decreased at least 50% and had a final score less than 10. Minimum score = 0 (best). Maximum score = 52 (worst). The 17 item scale assesses depression symptoms, including Depressed Mood, Feelings of Guilt, Suicidal Ideation, Insomnia, Anxiety, Weight Change, and Insight.

Outcome measures

Outcome measures
Measure
Electroacupuncture (EA)
n=28 Participants
Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.
Sham Acupuncture (SA)
n=25 Participants
Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.
Antidepressant Response, Defined as a Hamilton Depression Rating Scale Score Relative Decrease of 50 % or More and a Final Score < 10
11 participants
11 participants

SECONDARY outcome

Timeframe: Mean Change from Baseline to Post-Intervention Endpoint

Population: ITT, excluding the first four sham acupuncture subjects, whom the primary acupuncturist erred in treating. Although he correctly used the sham electricity procedure, for these subjects he placed needles in the verum electroacupuncture points of GV-20 and Yin tang.

Mean change in scores on the Medical Outcomes Survey-Version 1 (MOS-36) PHYSICAL Component Score (MOSPCS) from baseline to post-intervention across treatment group. Minimum Score = 0 (worse); Maximum Score = 100 (better), Normed to be at 50 on a control population. Positive Mean Change scores indicate improvement (an increase in scale score/better).

Outcome measures

Outcome measures
Measure
Electroacupuncture (EA)
n=28 Participants
Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.
Sham Acupuncture (SA)
n=25 Participants
Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.
Change in Functioning and Health-related Quality of Life as Rated by the Medical Outcomes Survey-Version 1 (MOS-36) Physical Component Score (MOSPCS)
0.54 Units on a scale
Standard Deviation 6.92
-1.65 Units on a scale
Standard Deviation 7.98

SECONDARY outcome

Timeframe: Mean Change from Baseline to Post-Intervention Endpoint

Population: ITT, excluding the first four sham acupuncture subjects, whom the primary acupuncturist erred in treating. Although he correctly used the sham electricity procedure, for these subjects he placed needles in the verum electroacupuncture points of GV-20 and Yin tang.

Mean change in scores on the Medical Outcomes Survey-Version 1 (MOS-36) Mental Component Score (MOSMCS) from baseline to post-intervention across treatment group. Minimum Score = 0 (worse); Maximum Score = 100 (better) , Normed to be at 50 on a control population. Positive Mean Change scores indicate improvement (an increase in scale score).

Outcome measures

Outcome measures
Measure
Electroacupuncture (EA)
n=28 Participants
Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.
Sham Acupuncture (SA)
n=25 Participants
Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.
Change in Functioning and Health-related Quality of Life as Rated by the Medical Outcomes Survey-Version 1 (MOS-36) Mental Component Score (MOSMCS)
6.23 Units on a scale
Standard Deviation 13.62
14.12 Units on a scale
Standard Deviation 17.54

SECONDARY outcome

Timeframe: Mean Change from Baseline to Post-Intervention Endpoint

Population: ITT, excluding the first four sham acupuncture subjects, whom the primary acupuncturist erred in treating. Although he correctly used the sham electricity procedure, for these subjects he placed needles in the verum electroacupuncture points of GV-20 and Yin tang.

Mean change in scores on the Medical Outcomes Survey-Version 1 (MOS-36) Bodily Pain Index (MOSBPI) from baseline to post-intervention across treatment group. Minimum Score = 0 (more); Maximum Score = 100 (less). Positive Mean Change scores indicate improvement (an increase in scale score/less pain).

Outcome measures

Outcome measures
Measure
Electroacupuncture (EA)
n=28 Participants
Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.
Sham Acupuncture (SA)
n=25 Participants
Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.
Change in Functioning and Health-related Quality of Life as Rated by the Medical Outcomes Survey-Version 1 (MOS-36) Bodily Pain Index (MOSBPI)
-1.04 Units on a scale
Standard Deviation 18.27
6.81 Units on a scale
Standard Deviation 19.70

Adverse Events

Electroacupuncture (EA)

Serious events: 0 serious events
Other events: 23 other events
Deaths: 0 deaths

Sham Acupuncture (SA)

Serious events: 0 serious events
Other events: 25 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Electroacupuncture (EA)
n=28 participants at risk
Needles placed at traditional meridian locations, GV-20 (on the crown of the head) and yin tang (in the midline of the forehead roughly at the glabella) and treated with electrical stimulation.
Sham Acupuncture (SA)
n=29 participants at risk
Needles placed laterally on the scalp, not corresponding to any traditional meridians. No electrical stimulation delivered.
Psychiatric disorders
CONCENTRATION DIFFICULTIES
0.00%
0/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
10.3%
3/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Psychiatric disorders
ASTHENIA / LASSITUDE / INCREASED FATIGUABILITY
3.6%
1/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
6.9%
2/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Psychiatric disorders
SLEEPINESS / SEDATION
3.6%
1/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
3.4%
1/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Psychiatric disorders
FAILING MEMORY
3.6%
1/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
3.4%
1/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Psychiatric disorders
TENSION / INNER UNREST
3.6%
1/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
10.3%
3/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Psychiatric disorders
INCREASED DURATION OF SLEEP:
10.7%
3/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
13.8%
4/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Psychiatric disorders
REDUCED DURATION OF SLEEP:
25.0%
7/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
24.1%
7/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Psychiatric disorders
INCREASED DREAM ACTIVITY
32.1%
9/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
41.4%
12/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Psychiatric disorders
EMOTIONAL INDIFFERENCE
7.1%
2/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
6.9%
2/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Nervous system disorders
TREMOR
0.00%
0/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
3.4%
1/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Nervous system disorders
PARATHESIAS
0.00%
0/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
3.4%
1/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Nervous system disorders
HEADACHE
28.6%
8/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
13.8%
4/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Nervous system disorders
ACCOMMODATION DISTURBANCES
0.00%
0/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
3.4%
1/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Gastrointestinal disorders
NAUSEA / VOMITING
25.0%
7/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
10.3%
3/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Gastrointestinal disorders
DIARRHEA
3.6%
1/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
3.4%
1/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Gastrointestinal disorders
CONSTIPATION
0.00%
0/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
10.3%
3/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Renal and urinary disorders
MICTURITION DISTURBANCES
0.00%
0/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
3.4%
1/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Nervous system disorders
ORTHOSTATIC DIZZINESS
10.7%
3/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
10.3%
3/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Cardiac disorders
PALPITATIONS / TACHYCARDIA
7.1%
2/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
3.4%
1/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Skin and subcutaneous tissue disorders
INCREASED TENDENCY TO SWEATING
10.7%
3/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
3.4%
1/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Skin and subcutaneous tissue disorders
RASH
3.6%
1/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
6.9%
2/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Skin and subcutaneous tissue disorders
PRURITUS
3.6%
1/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
3.4%
1/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Skin and subcutaneous tissue disorders
PHOTOSENSITIVITY
7.1%
2/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
6.9%
2/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Metabolism and nutrition disorders
WEIGHT LOSS
0.00%
0/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
6.9%
2/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Reproductive system and breast disorders
MENORRHAGIA
0.00%
0/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
3.4%
1/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Reproductive system and breast disorders
DIMINISHED SEXUAL DESIRE
10.7%
3/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
17.2%
5/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Reproductive system and breast disorders
ERECTILE DYSFUNCTION
0.00%
0/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
3.4%
1/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Reproductive system and breast disorders
EJACULATORY DYSFUNCTION
0.00%
0/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
3.4%
1/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Reproductive system and breast disorders
ORGASMIC DYSFUNCTION
25.0%
7/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
13.8%
4/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
Reproductive system and breast disorders
DRY VAGINA
3.6%
1/28 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100
0.00%
0/29 • Weekly assessments from Baseline to Post-Intervention endpoint
SEMI-STRUCTURED INTERVIEW FOR THE Udvalg Fur Kliniske Undersogesler (UKU) SIDE EFFECTS RATING SCALE From the University of Pittsburgh. Adapted by Tracy Flynn, M.S. Ed. and Benoit H. Mulsant, M.D. from: Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987). The UKU side effect rating scale. Acta Psychitr Scand 334(Suppl): 1-100

Additional Information

Benoit H. Mulsant, MD

University of Pittsburgh

Phone: (416) 535-8501

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place